`
`Application No:
`
`15/310,132
`
`Foreign Priority claimed:
`
`0 Yes
`
`@ N0
`
`35 USC 119 (a-d) conditions met: D Yes
`Verified and Acknowledged:
`
`No
`
`D Met After Allowance
`|:|
`
`Examiner's Signature
`
`Initials
`
`Title:
`
`IMMUNOTHERAPY WITH BINDING AGENTS
`
`GROUP ART UNIT
`
`ATTORNEY DOCKET NO.
`
` FILING 0r 371(c) DATE
`
`11/10/2016
`
`RULE
`
`1643
`
`2293.1220001/PAC/E-H
`
`APPLICANTS
`
`ONCOMED PHARMACEUTICALS, INC., Redwood City, CA, UNITED STATES
`
`INVENTORS
`
`Austin L. GURNEY San Francisco, CA, UNITED STATES
`
`Ming-hong XIE Foster City, CA, UNITED STATES
`
`James Gordon PORTER Newark, CA, UNITED STATES
`
`CONTINUING DATA
`
`This application is a 371 of PCT/US15/30472 05/13/2015
`
`PCT/US15/30472 has PRO of 61992456 05/13/2014
`
`FOREIGN APPLICATIONS
`
`IF REQUIRED, FOREIGN LICENSE GRANTED**
`
`06/12/2017
`
`STATE OR COUNTRY
`
`UNITED STATES
`
`ADDRESS
`
`Sterne, Kessler, Goldstein & Fox P.L.L.C.
`
`1100 New York Avenue NW
`
`Washington, DC 20005
`UNITED STATES
`
`FILING FEE RECEIVED
`
`$280
`
`